FDA approves costly Bristol

Medical Marketing and MediaFDA approves costly Bristol-Myers drug combo for melanomaReutersThe U.S. Food and Drug Administration on Thursday approved the first combination of two drugs that help the immune system fight cancer, a therapy regimen that could cost $256,000 a year. Bristol-Myers Squibb Co said the FDA had given the green light to ...FDA gives early OK to combo cancer treatmentSalt Lake TribuneBristol-Myers Drug Combo Approved by FDA For Skin CancerWKRB NewsFive things for pharma marketers to know: Thursday, October 1, 2015Medical Marketing and MediaMedscapeall 38 news articles »